Planet 13 Holdings (PLNH) Share-based Compensation Growth (1y) (2022 - 2026)
Planet 13 Holdings (PLNH) Share-based Compensation Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Planet 13 Holdings | 51.22 Mn | 34.74 Mn | 12.32 Mn | 32.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.97% |
| Mar 31, 2026 | 1,050.76% |
| Dec 31, 2025 | 4,472.91% |
| Sep 30, 2025 | 2,326.24% |
| Jun 30, 2025 | 1,878.19% |
| Mar 31, 2025 | -42.18% |
| Dec 31, 2024 | 102.59% |
| Sep 30, 2024 | -97.41% |
| Jun 30, 2024 | -88.85% |
| Mar 31, 2024 | -85.53% |
| Dec 31, 2023 | -175.11% |
| Sep 30, 2023 | -51.90% |
| Jun 30, 2023 | -89.06% |
| Mar 31, 2023 | -41.85% |
| Dec 31, 2022 | -61.22% |
| Sep 30, 2022 | -69.19% |
| Jun 30, 2022 | -61.79% |
| Mar 31, 2022 | 507.83% |